Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

MT4

metallothionein IVMTIV


Gene MT4 gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Adult

70.0

Humans

1300.0

Male

120.0

Middle Aged

50.0

Cell Line

790.0

HIV Protease/metabolism

220.0

HIV-1/drug effects

24.0

Stereoisomerism

20.0

Structure-Activity Relationship

120.0

Virus Replication

182.0

English Abstract

110.0

HIV Infections/*virology

22.0

Research Support, Non-U.S. Gov't

860.0

HIV-1/*drug effects

1611.0

Animals

430.0

Spodoptera

20.0

3T3 Cells

20.0

Cell Division/drug effects

50.0

Cell Line, Transformed

100.0

Genetic Vectors

70.0

Giant Cells

23.0

Hamsters

30.0

Mice

160.0

Research Support, U.S. Gov't, P.H.S.

290.0

Transduction, Genetic

30.0

CD4-Positive T-Lymphocytes/virology

45.0

Comparative Study

160.0

Gene Therapy/*methods

30.0

HIV Infections/therapy

213.0

Retroviridae/*genetics

21.0

Species Specificity

30.0

Cattle

50.0

Chimeric Proteins/*genetics/metabolism

233.0

HIV-1/*genetics/metabolism/physiology

266.0

Transfection

80.0

HIV Infections/drug therapy

24.0

Anti-HIV Agents/*pharmacology

21.0

Cells, Cultured

200.0

Virus Replication/drug effects

135.0

COS Cells

20.0

Cercopithecus aethiops

50.0

*Genes, Viral

21.0

Leukocytes, Mononuclear/virology

32.0

Mutagenesis

20.0

RNA, Viral

24.0

Protein Binding

30.0

Rats

80.0

Rats, Sprague-Dawley

20.0

Crystallography, X-Ray

20.0

Drug Resistance, Microbial/genetics

33.0

Kinetics

100.0

Models, Molecular

20.0

Mutation

40.0

Protein Conformation

20.0

Anti-HIV Agents/*chemical synthesis/chemistry/*pharmacology

250.0

HIV-1/drug effects/physiology

318.0

Magnetic Resonance Spectroscopy

20.0

Microbial Sensitivity Tests

31.0

Molecular Structure

50.0

Antibodies, Monoclonal

40.0

Antiviral Agents/*pharmacology

1811.0

Dose-Response Relationship, Drug

40.0

In Vitro

30.0

Reproducibility of Results

30.0

Female

100.0

Pregnancy

30.0

Anti-HIV Agents/chemistry/*pharmacology

210.0

Anticoagulants/chemistry/*pharmacology

233.0

Antiviral Agents/chemistry/*pharmacology

220.0

Carbohydrates/chemistry/*pharmacology

2100.0

Diatoms/*chemistry

2100.0

Herpesvirus 1, Human/*drug effects

266.0

Plant Extracts/chemistry/pharmacology

220.0

Vero Cells

20.0

Gene Expression

30.0

HIV-1/*genetics

51.0

RNA, Viral/*genetics

511.0

Cytopathogenic Effect, Viral

74.0

Disease Progression

20.0

Time Factors

70.0

Virus Cultivation/methods

233.0

Flow Cytometry

20.0

Lipopolysaccharides/pharmacology

20.0

Tumor Cells, Cultured

80.0

Antigens, CD4/metabolism

30.0

Apoptosis/*physiology

20.0

Cell Division

20.0

*HIV-1

20.0

Drug Design

20.0

Antibody Specificity

20.0

Antigens, CD4/*immunology

20.0

HIV Infections/*immunology

20.0

Mice, Inbred BALB C

50.0

HIV-1/*drug effects/physiology

78.0

Gene Expression Regulation

20.0

*Genetic Vectors

30.0

Retroviridae/genetics

20.0

Base Sequence

250.0

Cloning, Molecular

50.0

DNA Primers

40.0

Mutagenesis, Site-Directed

50.0

Anti-HIV Agents/*chemistry/*pharmacology

225.0

HIV Antibodies/*biosynthesis

215.0

HIV-1/*immunology

30.0

HIV-1/*physiology

30.0

Lymphocytes/virology

210.0

RNA, Viral/*metabolism

24.0

Virus Replication/*drug effects

117.0

Amino Acid Sequence

180.0

Binding Sites

40.0

Biological Transport

30.0

Cell Nucleus/metabolism

40.0

Hela Cells

90.0

Molecular Sequence Data

350.0

Phenotype

40.0

Proviruses/genetics

69.0

HIV-1/drug effects/*enzymology

266.0

Microbial Sensitivity Tests/*methods

222.0

Membrane Fusion

21.0

T-Lymphocytes/virology

34.0

HIV-1/*pathogenicity/physiology

26.0

Polymerase Chain Reaction

110.0

DNA Replication/drug effects

21.0

HIV-1/physiology

22.0

Interferon-alpha/*pharmacology

21.0

Interferon-beta/*pharmacology

23.0

Transcription, Genetic/*drug effects

20.0

Virus Integration

23.0

HIV-1 Reverse Transcriptase/genetics

25.0

DNA, Viral/analysis

30.0

HIV-1/genetics/*physiology

54.0

RNA, Viral/analysis

31.0

*Virus Replication

62.0

*HIV Long Terminal Repeat

33.0

Macaca mulatta

20.0

Neutralization Tests

51.0

*Promoter Regions (Genetics)

20.0

*Repetitive Sequences, Nucleic Acid

20.0

AIDS Vaccines

216.0

B-Lymphocytes/*immunology

30.0

HIV-1/*immunology/physiology

25.0

Rabbits

20.0

Cell Transformation, Viral

41.0

Human T-lymphotropic virus 1/*genetics

35.0

Enzyme-Linked Immunosorbent Assay

70.0

HIV Envelope Protein gp120/*immunology

21.0

Blotting, Southern

30.0

Research Support, U.S. Gov't, Non-P.H.S.

50.0

Adenosine Deaminase/metabolism

210.0

Drug Resistance, Microbial

21.0

Half-Life

30.0

Macaca fascicularis

31.0

Aged

20.0

Biopsy

20.0

Sensitivity and Specificity

20.0

Cell Death

20.0

Drug Synergism

70.0

Nucleic Acid Conformation

30.0

RNA, Catalytic/*metabolism

213.0

Recombination, Genetic

20.0

Genes, Viral

20.0

Gene Expression/drug effects

20.0

Genes, pol/genetics

240.0

Lamivudine

216.0

T-Lymphocytes

41.0

Zalcitabine/*analogs & derivatives/pharmacology

266.0

Zidovudine/*pharmacology

623.0

HIV-1 Reverse Transcriptase

711.0

*Virus Integration

22.0

Cytopathogenic Effect, Viral/drug effects

939.0

HIV Core Protein p24/biosynthesis

24.0

RNA, Viral/biosynthesis

24.0

RNA/analysis

20.0

Oligodeoxyribonucleotides

30.0

Enzyme Activation

20.0

Biological Availability

20.0

Dogs

20.0

Interleukin-2/pharmacology

20.0

*Mutation

40.0

RNA-Directed DNA Polymerase/*genetics

225.0

Reverse Transcriptase Inhibitors

315.0

Zidovudine/pharmacology

610.0

Plasmids

40.0

Promoter Regions (Genetics)

30.0

RNA, Antisense/*genetics

26.0

Chromosome Mapping

20.0

T-Lymphocytes/microbiology

28.0

RNA-Directed DNA Polymerase/analysis

311.0

Thionucleosides/*pharmacology

2100.0

Microscopy, Electron

30.0

RNA-Directed DNA Polymerase/metabolism

45.0

Down-Regulation

20.0

Drug Screening Assays, Antitumor

20.0

DNA, Viral/genetics

21.0

Dideoxynucleosides/*pharmacology

337.0

HIV Antigens/analysis

25.0

Fluorescent Antibody Technique

40.0

*Cell Transformation, Viral

21.0

Blotting, Northern

20.0

Oligonucleotide Probes

30.0

Restriction Mapping

50.0

Chemotaxis, Leukocyte

21.0

Antibodies, Monoclonal/*immunology

30.0

T-Lymphocytes/immunology

20.0

Chromosome Deletion

20.0

Cytochrome c Group/genetics

233.0

Sequence Homology, Nucleic Acid

20.0

Transcription, Genetic

20.0

HIV/*drug effects

312.0

Giant Cells/immunology

216.0

Plaque Assay

22.0

HIV/*drug effects/physiology

220.0

Phosphorylation

20.0

Deoxyadenosines/*analogs & derivatives/pharmacology

266.0

*Dideoxyadenosine/*analogs & derivatives

266.0

Trans-Activation (Genetics)

20.0

HLA-DR Antigens

30.0

HLA-DR4 Antigen

23.0

Genes, MHC Class II

20.0

Electrophoresis, Polyacrylamide Gel

20.0